Skip to main content

Blood Cancer 201: Moving Beyond the basics of Disease, Treatment and the Role of the HCP

Coming soon! 


 

Target Audience

This accredited CE activity is intended for social workers, nurses, and other healthcare professionals involved in the care of patients with hematologic malignancies.

Course Content Level for Social Workers: Intermediate and advanced 
Format: Noninteractive recorded webinar

 

Description

This webinar will provide a more in-depth overview of blood cancers. Pertinent information to be discussed will include the role of genomics and molecular profiling in the diagnosis, prognostication, treatment, and monitoring of patients with hematologic malignancies. The program will also explore the various treatment modalities available for blood cancer patients including clinical trials. Discussion of the psychosocial impact of the disease with the inclusion of resources for patient and caregiver education and support will be provided to aid the multidisciplinary healthcare team in providing relevant, scientific, and holistic care to the blood cancer patient and caregiver.

 

Learning Objectives

After completing this activity, participants should be better able to:

  • Explain the role of genomics and molecular profiling in the diagnosis, prognostication, treatment, and monitoring of blood cancer.
  • Describe the psychosocial impact of different blood cancer diagnoses.
  • Explore treatment options for blood cancer patients including precision medicine, cellular therapy, and clinical trials.
  • List resources for patients with blood cancers and how to access them.

 

Faculty

Laura Romundstad, CRNP, MSN, RN
Clinical Trial Nurse Navigator
Clinical Trial Support Center 
The Leukemia & Lymphoma Society 
 
Lynn Steele, LSW, OSW-C
Information Specialist
Information Resource Center
The Leukemia & Lymphoma Society 


Continuing Education

Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 1.0 continuing education contact hour through the California Board of Registered Nursing.

The Leukemia & Lymphoma Society (LLS), provider number 1105, is approved as a provider for social work continuing education by the Association of Social Work Boards (ASWB) www.aswb.org Approved Continuing Education Program (ACE). Approval Period: 12/10/2020-12/10/2023. LLS maintains responsibility for the program. Social workers should contact their regulatory board to determine course approval. Social workers will receive 1.0 clinical CE contact hour. 

LLS is recognized by the New York State Education Departments State Board for Social Work as an approved provider of continuing education for licensed social workers #0117. LLS maintains responsibility for the program. Social workers will receive 1.0 clinical CE contact hours for this activity.

All continuing education credits are provided free of charge.

Participants must attend the webinar in its entirety and submit the online evaluation form to earn credit. Once submitted, the certificate will be generated as a PDF online.

There are no system requirements other than an internet connection.

 

Providers

This program is sponsored by The Leukemia & Lymphoma Society.

For questions, concerns, or for assistance for people with disabilities or grievances, please contact us at ProfEducation@LLS.org